Chlorhexidine Bathing to Prevent Hospital-acquired Infections: the CLEANS Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

247 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hospital-acquired infections (HAI) have been shown to increase length of hospital stay and mortality. Infections acquired during a hospital stay have been shown to be preventable. The skin of patients is considered a major reservoir for pathogens associated with hospital-acquired infections, and has been suggested as a potential target for interventions to reduce bacterial burden and subsequent risk of infection. The use of daily Chlorhexidine (CHG) bathing in intensive care patients has been advocated to reduce many of the infections in critically ill patients. However, the effectiveness of CHG bathing to reduce ICU infections has varied considerably among published trials, making the effectiveness of CHG bathing in ICU patients uncertain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units

NCT05919966

Central Line-associated Bloodstream Infection (CLABSI)

COMPLETED

Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections

NCT00130221

Nosocomial Infection Bacteremia Sepsis +3 more

COMPLETED PHASE1

Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit

NCT01640925

Cross Infection Pneumonia, Ventilator-associated Catheter-related Infections +2 more

COMPLETED NA

Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients

NCT02033187

Healthcare Associated Infections

COMPLETED PHASE4

Impact of Daily Bathing With Chlorhexidine in the Critical Patient

NCT02870062

Healthcare Associated Infections

UNKNOWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chlorhexidine Hospital-Acquired Infection Surgery Intensive Care Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control arm

Patients were daily bathed with soap and water only.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention arm

Patients were daily bathed with soap and water and then receive 2% Chlorhexidine bathing (Petel Skin care wipes, Likang LtD, shanghai, China).

Group Type EXPERIMENTAL

2% Chlorhexidine bathing

Intervention Type OTHER

Eight chlorhexidine-impregnated cloths are used in sequential order to wipe the body surfaces from neck to toe to avoid exposure of chlorhexidine to the mucous membranes of the eyes, ears and mouth.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2% Chlorhexidine bathing

Eight chlorhexidine-impregnated cloths are used in sequential order to wipe the body surfaces from neck to toe to avoid exposure of chlorhexidine to the mucous membranes of the eyes, ears and mouth.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults (≥ 18-years old)
* anticipated SICU stay for 48 hours or more
* APACHE II \>15

Exclusion Criteria

* Braden Scale for Predicting Pressure Sore Risk score more than 9 (highest risk)
* pregnancy
* skin irritation
* chlorhexidine allergy
* SICU stay of more than 48 hours prior to screening

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No